Patients should seek medical evaluation for severe pain after injury, inability to bear weight, major swelling, deformity, numbness, weakness, fever, signs of infection, worsening abdominal pain, blood in stool, persistent vomiting, chest pain, shortness of breath, or neurological symptoms
The half-life of tirzepatide is approximately five days, allowing weekly dosing to maintain therapeutic plasma levels throughout the dosing interval
These include antibiotics, analgesics, anticoagulants, and cardiovascular agents stocked in standard hospital formularies
It changes the concentration, which changes how much liquid you need to draw per dose